Literature DB >> 17365977

Peak CKMB and cTnT accurately estimates myocardial infarct size after reperfusion.

Erik Hedström1, Karin Aström-Olsson, Hans Ohlin, Fredrik Frogner, Marcus Carlsson, Therese Billgren, Stefan Jovinge, Peter Cain, Galen S Wagner, Håkan Arheden.   

Abstract

OBJECTIVES: To find the time-to-peak for creatine kinase MB(mass) (CKMB) and cardiac troponin T (cTnT) after acute reperfusion, to compare peak and cumulative values to estimate infarct size (IS), and to evaluate clinical routine sampling for assessment of IS.
DESIGN: Acute primary percutaneous coronary intervention (PCI) was performed in 38 patients with first-time myocardial infarction. In 21 patients, CKMB and cTnT were acquired before PCI and at 1.5, 3, 6, 12, 18, 24, and 48 hours thereafter. In 17 patients, clinical routine samples were acquired at arrival, and at 10 and 20 h. IS was assessed by delayed contrast-enhanced MRI (DE-MRI).
RESULTS: Time-to-peak was 7.6+/-3.6 h for CKMB and 8.1+/-3.4 h for cTnT. Peak values correlated strongly to cumulative values (r(s)=0.97-0.98) as well as to DE-MRI (r(s)=0.8-0.82). Clinical routine sampling showed lower rs values (0.47-0.60).
CONCLUSIONS: Peak values are likely captured if CKMB and cTnT are acquired at 3, 6, and 12 h after acute PCI. These peak values can be used to estimate myocardial infarct size after acute PCI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17365977     DOI: 10.1080/14017430601071849

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  14 in total

1.  Troponin T levels and infarct size by SPECT myocardial perfusion imaging.

Authors:  Adelaide M Arruda-Olson; Véronique L Roger; Allan S Jaffe; David O Hodge; Raymond J Gibbons; Todd D Miller
Journal:  JACC Cardiovasc Imaging       Date:  2011-05

2.  Retrospective analysis of thrombolysis therapy for 64 cases of acute myocardial infarction with elevated ST segment.

Authors:  Xiao-xia Fu; Wen-jian Xiao; Jian Lu; Le-wen Wu; Fan Yang
Journal:  Chin J Integr Med       Date:  2010-01-18       Impact factor: 1.978

3.  Multi-vessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience.

Authors:  A A Khattab; M Abdel-Wahab; C Röther; B Liska; R Toelg; G Kassner; V Geist; G Richardt
Journal:  Clin Res Cardiol       Date:  2007-08-17       Impact factor: 5.460

4.  Osteopontin protects against cardiac ischemia-reperfusion injury through late preconditioning.

Authors:  Yongyi Wang; Baofu Chen; Dafu Shen; Song Xue
Journal:  Heart Vessels       Date:  2009-04-01       Impact factor: 2.037

5.  Peak CK-MB has a strong association with chronic scar size and wall motion abnormalities after revascularized non-transmural myocardial infarction - a prospective CMR study.

Authors:  Pauli Pöyhönen; Minna Kylmälä; Paula Vesterinen; Sari Kivistö; Miia Holmström; Kirsi Lauerma; Heikki Väänänen; Lauri Toivonen; Helena Hänninen
Journal:  BMC Cardiovasc Disord       Date:  2018-02-08       Impact factor: 2.298

6.  Efficacy and Mechanism of Preoperative Simvastatin Therapy on Myocardial Protection after Extracorporeal Circulation.

Authors:  Ping Hua; Jianyang Liu; Jun Tao; Rongjun Zou; Xifeng Lin; Dingwen Zhang; Songran Yang
Journal:  Biomed Res Int       Date:  2017-11-08       Impact factor: 3.411

7.  Association of Serum Copeptin Levels with Patency of Infarct-Related Arteries in Patients with ST-Segment Elevation Myocardial Infarction.

Authors:  Birsen Doganay; Sercan Okutucu; Mustafa Cetin; Emrullah Kızıltunc; Orhan Karayigit; Can Ozkan; Muhammed Fevzi Kılınckaya; Ender Ornek
Journal:  Acta Cardiol Sin       Date:  2019-07       Impact factor: 2.672

8.  Biomarkers and mortality in severe Chagas cardiomyopathy.

Authors:  Jacqueline E Sherbuk; Emi E Okamoto; Morgan A Marks; Enzo Fortuny; Eva H Clark; Gerson Galdos-Cardenas; Angel Vasquez-Villar; Antonio B Fernandez; Thomas C Crawford; Rose Q Do; Jorge Luis Flores-Franco; Rony Colanzi; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

9.  Methods of creatine kinase-MB analysis to predict mortality in patients with myocardial infarction treated with reperfusion therapy.

Authors:  Renato D Lopes; Yuliya Lokhnygina; Victor Hasselblad; Kristin L Newby; Eric Yow; Christopher B Granger; Paul W Armstrong; Judith S Hochman; James S Mills; Witold Ruzyllo; Kenneth W Mahaffey
Journal:  Trials       Date:  2013-05-02       Impact factor: 2.279

10.  Serum interferon-gamma-inducible protein 10 level was increased in myocardial infarction patients, and negatively correlated with infarct size.

Authors:  Kazuya Koten; Satoshi Hirohata; Toru Miyoshi; Hiroko Ogawa; Shinichi Usui; Ryoko Shinohata; Mutsumi Iwamoto; Tomoki Kitawaki; Shozo Kusachi; Kosaku Sakaguchi; Tohru Ohe
Journal:  Clin Biochem       Date:  2007-10-11       Impact factor: 3.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.